A recent study has identified a protein that plays a crucial role in regulating inflammation, potentially mitigating frailty and improving physical health in aging populations.
In a significant advancement in aging research, scientists have identified a protein that could play a pivotal role in combatting frailty and improving the overall physical health of aging individuals. The study, led by Keith Kirkwood, senior associate dean for research and Centennial Endowed Chair in the Department of Oral Biology at the School of Dental Medicine, highlights the protein tristetraprolin (TTP) as a key regulator of inflammation that tends to diminish with age.
The aging population in the United States is rapidly increasing, with projections indicating that by 2050, nearly one in four Americans will be 65 years or older. This demographic shift raises pressing concerns about healthcare systems and the quality of life for older adults, particularly as they face biological challenges associated with aging.
Understanding Inflammaging
Chronic inflammation, often referred to as “inflammaging,” is a common feature of aging, leading to various health conditions such as arthritis, fatigue, and muscle weakness. Kirkwood explains that age-related changes, collectively known as immunosenescence, contribute to a decline in immune resilience, heightening susceptibility to chronic inflammatory diseases. “These age-related changes lead to a decline in immune resilience and an increased susceptibility to age-related chronic inflammatory diseases,” he states.
Research on TTP
The recent study explored the potential of TTP, a protein that binds RNA and plays a critical role in the regulation of inflammatory responses. Under normal physiological conditions, TTP helps to suppress inflammatory signals. However, its levels decline with age, particularly within immune cells, resulting in increased inflammation.
Over six years, supported by a $2.1 million grant from the National Institutes of Health (NIH), Kirkwood and his team conducted experiments involving genetically modified older mice. These mice were engineered to maintain stable levels of TTP, allowing researchers to observe the effects on physical frailty. The findings indicated that mice with stabilized TTP exhibited significantly lower frailty compared to untreated counterparts. This study was published in the January 2026 issue of the journal Aging and Disease.
Study Findings
The research team assessed physical performance through various tests, including grip strength, walking speed, and endurance trials. Results showed that male mice with elevated TTP levels had improved grip strength and overall physical performance. Female mice also showed improvements, although the effects were less pronounced, which Kirkwood attributes to factors such as body size and estrogen levels. “The increase in TTP resulted in better grip strength, better walking, endurance, and overall physical performance,” Kirkwood noted. “These mice had healthier bones and reduced bone breakdown, exhibiting a more youthful-looking immune profile.”
Implications for Human Health
While the results from these animal studies are promising, Kirkwood acknowledges that translating these findings into human treatments will require extensive research. Perry Blackshear, a collaborator on the study, has initiated early drug screening to identify compounds that could effectively increase TTP levels, although no effective candidate has yet been identified. “We would like to close that gap in the future,” Kirkwood stated, expressing optimism about the potential applications of TTP modulation in human health. The research team is also exploring the role of TTP in neuroinflammation related to conditions such as dementia and Alzheimer’s disease.
Future Directions
The ongoing collaboration between Kirkwood and postdoctoral researcher Ramkumar Thiyagarajan aims to further investigate the implications of TTP in various aging-related diseases. As Kirkwood concluded, “I’m optimistic about where this research could lead and what we may learn as studies continue over time.”
This study underscores the critical intersection of aging research and immunology, providing a foundation for potential interventions that could enhance the quality of life for older adults facing the challenges of aging. The work not only sheds light on the biological mechanisms behind aging but also raises hopes for future therapies that could address the debilitating effects of age-related frailty.
As the U.S. population ages, with an increasing number of individuals living into their 90s and beyond, the need for effective interventions becomes more pressing. Health care systems will face significant strain as they adapt to meet the needs of an older demographic. Research such as this provides a glimpse into potential strategies for improving health outcomes and ensuring that aging individuals maintain a higher quality of life.
In summary, the study led by Kirkwood and his team offers a novel insight into how manipulating levels of TTP could lead to enhanced physical health and decreased frailty in aging populations. The findings could pave the way for innovative therapies aimed at mitigating the effects of aging, ultimately contributing to healthier and more active lives for older adults.
